Biotechnology
-
BMY Stock: Precision Medicine & Immunotherapy in Cancer Treatment
Explore how Bristol-Myers Squibb pioneers cancer treatment using precision medicine & immunotherapy for improved patient outcomes and survival rates.
-
Daily Stock Watch: Is Kymera a Buy?
Biotech outfit Kymera Therapeutics (NASDAQ: KYMR) is heading upwards on the back of positive clinical trial news. But is KYMR stock a good investment?
-
Is Ginkgo Bioworks Stock A Good Buy?
The Ginkgo Bioworks (NYSE: DNA) share price is beaten down this year. We look at whether DNA Stock is a good buy.
-
IPO Preview: SAVU, KWE, BFAI
The upcoming IPOs in focus this week include lab-grown organ outfit BioLife4D Corp, non-lethal weapons developer Kwesst and AI healthcare...
-
Daily Stock Watch: Is Veeva Systems a Buy?
Shares of Veeva Systems Inc (NYSE: VEEV) are markedly lower on Friday on the back of earnings disappointment. But with few competitors and a...
-
Daily Stock Watch: HZNP Climbs on Buyout Rumblings
Horizon Therapeutics (NASDAQ: HZNP) has seen its share price leap on the back of M&A news, but does that mean HZNP stock is a good investment?
-
Daily Stock Watch: ISEE Stock's Eye Watering Rise
Iveric Bio Inc (NASDAQ: ISEE) has seen its share price leap following a new FDA designation. However, with good news for a key competitor emerging...
-
IPO Outlook: GNLX, BFAI
The IPOs to look out for this week include cancer treatment outfit Genelux Corporation and medicine development and AI specialist BullFrog AI.
-
Daily Stock Watch: Biotech Stock BLI Rises 20%
Berkeley Lights (NASDAQ: BLI) released Q3 earnings with record recurring revenues, leading the BLI share price to rise 20%.
-
IPO Outlook: BFAI, SNAL, ACRV
The IPOs to look out for this week include medicine development and AI specialist BullFrog AI, game developer Snail and biopharma outfit Acrivon...
-
Daily Stock Watch: Aurinia Pharmaceuticals Slashes Sales Forecast
Aurinia Pharmaceuticals (NASDAQ: AUPH) has seen its share price fall yet further as Q3 results included a cut in sales forecast. But is AUPH stock...
-
Daily Stock Watch: ESSA Pharma Dips on Trial Suspension
Though ESSA Pharma Inc (NASDAQ: EPIX) saw its share price soar last week on strong pre-clinical news, a trial hiccup is giving investors jitters....
-
IPO Outlook: MBLY, ASPI, INTS
The coming week's IPOs could include offerings from Mobileye Global (NASDAQ: MBLY), ASP Isotopes (NASDAQ: ASPI) and Intensity Therapeutics (NASDAQ:...
-
Daily Stock Watch: IMUX Stock Tumbles on Placebo Performance
Immunic Inc (NASDAQ: IMUX) has lost three quarters of its share price after investors were left unimpressed with clinical trial data. But is IMUX...
-
Daily Stock Watch: MIST Stock Falters Despite Trial Success
One stock heading lower at the start of this week is biopharma outfit Milestone Pharmaceuticals (NASDAQ: MIST). But is MIST stock a good investment?
-
IPO Outlook: ALPX, BMR, ASPI, INTS, PRME
The coming week's IPOs could include offerings from Alopexx (NASDAQ: ALPX), Beamr Imaging (NASDAQ: BMR), ASP Isotopes (NASDAQ: ASPI), Intensity...